Drug Profile
SP 12054
Alternative Names: SP12054Latest Information Update: 28 Oct 2020
Price :
$50
*
At a glance
- Originator Spherium Biomed
- Class Antineoplastics
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Actinic keratosis; Skin cancer
Most Recent Events
- 28 Oct 2020 No recent reports of development identified for preclinical development in Actinic keratosis in Spain (Topical)
- 28 Oct 2020 No recent reports of development identified for preclinical development in Skin-cancer in Spain (Topical)